Mirdametinib in Histiocytic Disorders
Conditions: Langerhans Cell Histiocytosis (LCH); Juvenile Xanthogranuloma (JXG); Rosai-Dorfman Disease (RDD); Histiocytic Disorders Interventions: Drug: Mirdametinib Sponsors: Children ' s Hospital Medical Center, Cincinnati Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Histiocytosis | Hospitals | Langerhans Cell Histiocytosis (LCH) | Research | Rosai-Dorfman Disease